Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: A population based study

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 9, 2012, Pages 528-531

  Mohebbi, Seyed Reza ^a   Rostami Nejad, Mohammad ^a   Tahaei, Seyed Mohammad Ebrahim ^a   Pourhoseingholi, Mohammad Amin ^a   Habibi, Manijeh ^a   Azimzadeh, Pedram ^a   Naghoosi, Hamed ^a   Karayiannis, Peter ^b   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Hepatitis A; Hepatitis E; Iran; Seroepidemiology; Tehran

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS E ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS E; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS ANTIBODIES; HEPATITIS E; HUMANS; IMMUNIZATION PROGRAMS; IMMUNOGLOBULIN G; INFANT; IRAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

HEPATITIS A VIRUS; HEPATITIS E VIRUS;

EID: 84864815364     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.05.013     Document Type: Article

References (35)

1. Cuthbert J.A. Hepatitis A: old and new. Clin Microbiol Rev 2001, 14:35-38.
2. Kemmer N.M., Miskovsky E.P. Hepatitis A. Infect Dis Clin North Am 2000, 14:605-615.
3. Rajan E., Shattock A., Fielding J. Cost-effective analysis of hepatitis A prevention in Ireland. Am J Gastroenterol 2000, 95:223-226.
4. Panda S.K., Thakral D., Rehman S. Hepatitis E virus. Rev Med Virol 2007, 17:151-180.
5. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009, 24:1484-1493.
6. Ehsaniardekani M.J., JafariMehr A., Hedayati M., Zali M.R. Serologic frequency of Hepatitis A in children who were referred to Tehran pediatric hospitals in 2001. J Zanjan Univ Med Sci Health Serv 2002, 10:35-38.
7. Gachkar L., Taremi M., Mahmoodarabi S., et al. Frequency of antibodies to hepatitis E virus among male blood donors in Tabriz. BLOOD (KHOON) 2005, 2:157-162.
8. Moradi A., Besharat S., Minaiifar M.M., Roshandel G., Tabaraii A. Seroepidemiologic assessment of Hepatitis E virus in women of reproductive age, Gorgan. Zahedan J Res Med Sci 2010, 12:44-47.
9. Mathur P., Arora N. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res 2008, 128:699-704.
10. Van Hoecke C., Lebacq E., Beran J., Prymula R., Collard F. Concomitant vaccination against hepatitis A and typhoid fever. J Travel Med 1998, 5:116-120.
11. WHO. Hepatitis A. Geneva: World Health Organization; 2000. [accessed 2 November 2010]. http://www.who.int/csr/disease/hepatitis/whocdscsredc2007/en/index.html.
12. Carrilho F. Epidemiology of hepatitis A and E virus infection in Brazil. Gastroenterol Hepatol 2005, 28:118-125.
13. WHO. Hepatitis E. Geneva: World Health Organization; 2001. [accessed 3 November 2010]. http://www.who.int/emc-documents/hepatitis/docs/whocdscsredc200112.pdf/HepatitisEwithTitlePage.pdf.
14. Stoszek S.K., Engle R.E., Abdel-Hamid M., et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Tro Med Hyg 2006, 100:89-94.
15. Dalton H.R., Stableforth W., Thurairajah P., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:784-790.
16. Takeda H., Matsubayashi K., Sakata H., et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010, 99:307-313.
17. Agboatwalla M., Isomura S., Miyake K., Yamashita T., Morishita T., Akram D.S. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr 1994, 61:545-549.
18. El-Hazmi M. Hepatitis A antibodies: prevalence in Saudi Arabia. J Trop Med Hyg 1989, 92:427-430.
19. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000, 18(Suppl 1):S65-S67.
20. Ungan M., Yaman H., Taheri N. The seroprevalence of specific antibodies to hepatitis A virus in a Turkish population. Eur J Gastroenterol Hepatol 2002, 14:1033-1034.
21. Hamid S.S., Atiq M., Shehzad F., et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002, 36:474-478.
22. Atabek M.E., Fyndyk D., Gulyuz A., Erkul I. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy 2004, 67:265-269.
23. CDC. Hepatitis E information for health professionals. Atlanta: Centers for Disease Control and Prevention; 2009. [accessed 17 May 2012]. http://www.cdc.gov/hepatitis/HEV/HEVfaq.htm.
24. CDC. Hepatitis A. Atlanta: Centers for Disease Control and Prevention; 2011. [accessed 17 May 2012]. http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/hepatitis-a.htm%232394.
25. Rezazadeh M., Hahiloui M., Ghachkar L., Iadegari D., Kashani K.M., Naghdi M. Study of antibody prevalence against Hepatitis E in blood donors in Hamedan. Infect Trop Dis 2005, 11:13-18.
26. Ghorbani G., Alavian S.M., Lorgardezfoolinejhad M. Frequency of HAV and HEV in military personnel. Iranian J Infect Dis Trop Med 2008, 13:39-42.
27. Ghadir M., Jafari E., Rezvan H., Amini Kafiabad S., Vahezjavadi M., Pourshams A. Hepatitis A and E in the east of Golestan province. J Med Council IRI 2007, 25:34-38.
28. Ataei B., Nokhodian Z., Javadi A., Kasaeian N., Farajzadegan Z., Shoaei P. Seroepidemiology of Hepatitis A virus in over 6 years population in Isfahan-Iran. J Isfahan Med School 2007, 25:46-53.
29. Ataei B., Nokhodian Z., Javadi A.A., et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis 2009, 13:67-71.
30. Montazem S.H., Kafshnoochi M., Tanoomand A. Age-specific prevalence of antibodies to hepatitis A in rural and urban population of Malekan city. Med Sci J Islamic Azad Univ 2007, 17:41-44.
31. Houri R. Epidemiology of viral Hepatitis in Iran. In: The first international Symposium of Hepatitis. Tehran: Blood Transfusion Organization; 1993; p. 51-3.
32. Alavi S.M., Ahmadi F., Ghasemirad M.R., Nikkhoi A. Study of association between seroprevalence of Hepatitis E and intravenous addiction in rehabilitation centers of Ahvaz between 2005-2006. J Shahrekord Univ Med Sci 2007, 9:15-20.
33. Saffar M.J., Farhadi R., Ajami A., Khalilian A., Babamahmoodi F., Shojahi J. Seroepidemiology of HEV infection in Saravi 2-25 years old in 2004. J Mazanderan Univ Med Sci 2006, 15:75-82.
34. Kaya D., Guler E., Ekerbicer H., et al. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat 2007, 14:830-834.
35. Amin J., Gilbert G.L., Escott R.G., Heath T.C., Burgess M.A. Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust 2001, 174:338-341.